Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Schulze-Koops et al .
Annals of the rheumatic diseases(2020)
Abstract
We appreciate the interest of Dr Schulze-Koops and colleagues in our article.1 The role of the inflammatory rheumatic diseases (IRDs), their therapies and other potential factors in the risk of SARS-CoV-2 infection and course of COVID-19 disease are a topic in a constant update. In this sense, we consider that our study provides additional evidence in patients with IRD regarding susceptibility to moderate-severe infection related to COVID-19.2\n\nIt is important to note that SARS-CoV-2/COVID-19 is a very changing epidemiological scenario. Our manuscript is a real-world longitudinal study performed during the period of maximum health emergency due to the COVID-19 pandemic in Madrid, the epicentre of the outbreak in Spain. We included all patients …
MoreTranslated text
Key words
autoimmune diseases,epidemiology,health care,outcome assessment
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined